An ER Translocon for Multi-Pass Membrane Protein Biogenesis
Total Page:16
File Type:pdf, Size:1020Kb

Load more
Recommended publications
-
FK506-Binding Protein 12.6/1B, a Negative Regulator of [Ca2+], Rescues Memory and Restores Genomic Regulation in the Hippocampus of Aging Rats
This Accepted Manuscript has not been copyedited and formatted. The final version may differ from this version. A link to any extended data will be provided when the final version is posted online. Research Articles: Neurobiology of Disease FK506-Binding Protein 12.6/1b, a negative regulator of [Ca2+], rescues memory and restores genomic regulation in the hippocampus of aging rats John C. Gant1, Eric M. Blalock1, Kuey-Chu Chen1, Inga Kadish2, Olivier Thibault1, Nada M. Porter1 and Philip W. Landfield1 1Department of Pharmacology & Nutritional Sciences, University of Kentucky, Lexington, KY 40536 2Department of Cell, Developmental and Integrative Biology, University of Alabama at Birmingham, Birmingham, AL 35294 DOI: 10.1523/JNEUROSCI.2234-17.2017 Received: 7 August 2017 Revised: 10 October 2017 Accepted: 24 November 2017 Published: 18 December 2017 Author contributions: J.C.G. and P.W.L. designed research; J.C.G., E.M.B., K.-c.C., and I.K. performed research; J.C.G., E.M.B., K.-c.C., I.K., and P.W.L. analyzed data; J.C.G., E.M.B., O.T., N.M.P., and P.W.L. wrote the paper. Conflict of Interest: The authors declare no competing financial interests. NIH grants AG004542, AG033649, AG052050, AG037868 and McAlpine Foundation for Neuroscience Research Corresponding author: Philip W. Landfield, [email protected], Department of Pharmacology & Nutritional Sciences, University of Kentucky, 800 Rose Street, UKMC MS 307, Lexington, KY 40536 Cite as: J. Neurosci ; 10.1523/JNEUROSCI.2234-17.2017 Alerts: Sign up at www.jneurosci.org/cgi/alerts to receive customized email alerts when the fully formatted version of this article is published. -
Accurate Annotation of Human Protein-Coding Small Open Reading Frames
HHS Public Access Author manuscript Author ManuscriptAuthor Manuscript Author Nat Chem Manuscript Author Biol. Author Manuscript Author manuscript; available in PMC 2020 June 09. Published in final edited form as: Nat Chem Biol. 2020 April ; 16(4): 458–468. doi:10.1038/s41589-019-0425-0. Accurate annotation of human protein-coding small open reading frames Thomas F. Martinez1,*, Qian Chu1, Cynthia Donaldson1, Dan Tan1, Maxim N. Shokhirev2, Alan Saghatelian1,* 1Clayton Foundation Laboratories for Peptide Biology, Salk Institute for Biological Studies, La Jolla, California 92037, USA 2Razavi Newman Integrative Genomics Bioinformatics Core, Salk Institute for Biological Studies, La Jolla, California 92037, USA Abstract Functional protein-coding small open reading frames (smORFs) are emerging as an important class of genes. However, the number of translated smORFs in the human genome is unclear because proteogenomic methods are not sensitive enough, and, as we show, Ribo-Seq strategies require additional measures to ensure comprehensive and accurate smORF annotation. Here, we integrate de novo transcriptome assembly and Ribo-Seq into an improved workflow that overcomes obstacles with previous methods to more confidently annotate thousands of smORFs. Evolutionary conservation analyses suggest that hundreds of smORF-encoded microproteins are likely functional. Additionally, many smORFs are regulated during fundamental biological processes, such as cell stress. Peptides derived from smORFs are also detectable on human leukocyte antigen complexes, revealing smORFs as a source of antigens. Thus, by including additional validation into our smORF annotation workflow, we accurately identify thousands of unannotated translated smORFs that will provide a rich pool of unexplored, functional human genes. Annotation of open reading frames (ORFs) from genome sequencing was initially carried out by locating in-frame start (AUG) and stop codons1–3. -
Mutants in Three Novel Complementation Groups Inhibit
Mutants in Three Novel Complementation Groups Inhibit Membrane Protein Insertion into and Soluble Protein Translocation across the Endoplasmic Reticulum Membrane of Saccharomyces cerevisiae Neil Green,* Hong Fang, $ and Peter Walter* *Department ofBiochemistry and Biophysics, School ofMedicine, University of California, San Francisco, California 94143-0448; and tDepartment of Microbiology and Immunology, School ofMedicine, Vanderbilt University, Nashville, Tennessee 37232-2363 Abstract. We have isolated mutants that inhibit mem- tations in SEC61 and SEC63, which were previously brane protein insertion into the ER membrane of Sac- isolated as mutants inhibiting the translocation of solu- charomyces cerevisiae. The mutants were contained in ble proteins, also affect the insertion of membrane three complementation groups, which we have named proteins into the ER. Taken together our data indicate SEC70, SEC1, and SEC72. The mutants also inhib- that the process of protein translocation across the ER ited the translocation of soluble proteins into the lu- membrane involves a much larger number of gene men of the ER, indicating that they pleiotropically products than previously appreciated . Moreover, differ- affect protein transport across and insertion into the ent translocation substrates appear to have different re- ER membrane. Surprisingly, the mutants inhibited the quirements for components of the cellular targeting translocation and insertion of different proteins to dras- and translocation apparatus . tically different degrees. We have also shown that mu- SCENT genetic studies in Saccharomyces cerevisiae Interestingly, not all proteins passing through the secretory have shown that the SEC61, SEC62, and SEC63 pathway were equally affected by mutations in SEC61, SEC- genes are required for secretory protein translocation 62, and SEC63 ; the translocation of pre-invertase showed into the lumen of the ER (Deshaies and Schekman, 1987; little inhibition in mutant cells (Rothblatt et al., 1989) and Rothblatt et al., 1989). -
SEC62 Rabbit Polyclonal Antibody – TA319720 | Origene
OriGene Technologies, Inc. 9620 Medical Center Drive, Ste 200 Rockville, MD 20850, US Phone: +1-888-267-4436 [email protected] EU: [email protected] CN: [email protected] Product datasheet for TA319720 SEC62 Rabbit Polyclonal Antibody Product data: Product Type: Primary Antibodies Applications: IF, IHC, WB Recommended Dilution: WB: 0.5 - 1 ug/mL, ICC: 5 ug/mL, IF: 20 ug/mL Reactivity: Human, Mouse, Rat Host: Rabbit Isotype: IgG Clonality: Polyclonal Immunogen: SEC62 antibody was raised against an 18 amino acid synthetic peptide near the carboxy terminus of human SEC62. Formulation: SEC62 Antibody is supplied in PBS containing 0.02% sodium azide. Concentration: 1ug/ul Purification: SEC62 Antibody is affinity chromatography purified via peptide column. Conjugation: Unconjugated Storage: Store at -20°C as received. Stability: Stable for 12 months from date of receipt. Gene Name: SEC62 homolog, preprotein translocation factor Database Link: NP_003253 Entrez Gene 69276 MouseEntrez Gene 294912 RatEntrez Gene 7095 Human Q99442 Background: SEC62 Antibody: SEC62 is an integral membrane protein located in the rough endoplasmic reticulum (ER) and is part of the SEC61-SEC62-SEC63 complex that is the central component of the protein translocation apparatus of the ER membrane. It is speculated that SEC61- SEC62-SEC63 may perform post-translational protein translocation into the ER and might also perform the backward transport of ER proteins that are subject to the ubiquitin-proteasome- dependent degradation pathway. Silencing of this gene with RNAi dramatically reduced the migration and invasive potential of numerous tumor cell lines, suggesting that it may be an attractive target for therapy of various tumors. -
The Signal Recognition Particle
P1: GDL May 22, 2001 22:53 Annual Reviews AR131-22 Annu. Rev. Biochem. 2001. 70:755–75 Copyright c 2001 by Annual Reviews. All rights reserved THE SIGNAL RECOGNITION PARTICLE Robert J. Keenan1, Douglas M. Freymann2, Robert M. Stroud3, and Peter Walter3,4 1Maxygen, 515 Galveston Drive, Redwood City, California 94063; e-mail: [email protected] 2Department of Molecular Pharmacology and Biological Chemistry, Northwestern University Medical School, Chicago, Illinois 60611; e-mail: [email protected] 3Department of Biochemistry and Biophysics, University of California, San Francisco, California 94143; e-mail: [email protected] 4The Howard Hughes Medical Institute, University of California, San Francisco, California 94143; e-mail: [email protected] Key Words Alu domain, SRP, SRP54, Ffh, SRP receptor, FtsY, signal sequence, GTPase, SRP9/14, SRP RNA ■ Abstract The signal recognition particle (SRP) and its membrane-associated re- ceptor (SR) catalyze targeting of nascent secretory and membrane proteins to the protein translocation apparatus of the cell. Components of the SRP pathway and salient fea- tures of the molecular mechanism of SRP-dependent protein targeting are conserved in all three kingdoms of life. Recent advances in the structure determination of a number of key components in the eukaryotic and prokaryotic SRP pathway provide new insight into the molecular basis of SRP function, and they set the stage for future work toward an integrated picture that takes into account the dynamic and contextual properties of this remarkable cellular machine. CONTENTS INTRODUCTION ................................................ 756 by UNIVERSITY OF CHICAGO LIBRARIES on 11/05/07. For personal use only. COTRANSLATIONAL PROTEIN TARGETING ..........................756 Annu. -
Ma-And-Mayr-Cell-2018.Pdf
Article A Membraneless Organelle Associated with the Endoplasmic Reticulum Enables 30UTR-Mediated Protein-Protein Interactions Graphical Abstract Authors Weirui Ma, Christine Mayr Correspondence [email protected] In Brief ER-associated granules foster selective protein-protein interactions dictated by the nucleotide composition of the encoding mRNA. Highlights d TIS granules are membraneless organelles intertwined with the endoplasmic reticulum d TIS11B forms TIS granules that enrich or exclude specific mRNAs and proteins in vivo d TIS granules enable translation of mRNAs with AU-rich elements at an ER subdomain d Specific protein-protein interactions can only be formed in the TIS granule region Ma & Mayr, 2018, Cell 175, 1–15 November 29, 2018 ª 2018 Elsevier Inc. https://doi.org/10.1016/j.cell.2018.10.007 Please cite this article in press as: Ma and Mayr, A Membraneless Organelle Associated with the Endoplasmic Reticulum Enables 30UTR- Mediated Protein-Protein Interactions, Cell (2018), https://doi.org/10.1016/j.cell.2018.10.007 Article A Membraneless Organelle Associated with the Endoplasmic Reticulum Enables 30UTR-Mediated Protein-Protein Interactions Weirui Ma1 and Christine Mayr1,2,* 1Cancer Biology and Genetics Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA 2Lead Contact *Correspondence: [email protected] https://doi.org/10.1016/j.cell.2018.10.007 SUMMARY cesses, including signaling and the addition of post-translational modifications (Li et al., 2012; Su et al., 2016). Approximately half of human genes generate mRNAs One type of membraneless organelles are RNA granules that with alternative 30 untranslated regions (30UTRs). contain mRNA transcripts packaged into ribonucleoprotein as- Through 30UTR-mediated protein-protein interac- semblies (Han et al., 2012). -
A Clearer Picture of the ER Translocon Complex Max Gemmer and Friedrich Förster*
© 2020. Published by The Company of Biologists Ltd | Journal of Cell Science (2020) 133, jcs231340. doi:10.1242/jcs.231340 REVIEW A clearer picture of the ER translocon complex Max Gemmer and Friedrich Förster* ABSTRACT et al., 1986). SP-equivalent N-terminal transmembrane helices that The endoplasmic reticulum (ER) translocon complex is the main gate are not cleaved off can also target proteins to the ER through the into the secretory pathway, facilitating the translocation of nascent same mechanism. In this SRP-dependent co-translational ER- peptides into the ER lumen or their integration into the lipid membrane. targeting mode, ribosomes associate with the ER membrane via ER Protein biogenesis in the ER involves additional processes, many of translocon complexes. These membrane protein complexes them occurring co-translationally while the nascent protein resides at translocate nascent soluble proteins into the ER, integrate nascent the translocon complex, including recruitment of ER-targeted membrane proteins into the ER membrane, mediate protein folding ribosome–nascent-chain complexes, glycosylation, signal peptide and membrane protein topogenesis, and modify them chemically. In cleavage, membrane protein topogenesis and folding. To perform addition to co-translational protein import and translocation, distinct such varied functions on a broad range of substrates, the ER ER translocon complexes enable post-translational translocation and translocon complex has different accessory components that membrane integration. This post-translational pathway is widespread associate with it either stably or transiently. Here, we review recent in yeast (Panzner et al., 1995), whereas higher eukaryotes primarily structural and functional insights into this dynamically constituted use it for relatively short peptides (Schlenstedt and Zimmermann, central hub in the ER and its components. -
X-Ray Structure of a Protein-Conducting Channel
articles X-ray structure of a protein-conducting channel Bert van den Berg1*, William M. Clemons Jr1*, Ian Collinson2, Yorgo Modis3, Enno Hartmann4, Stephen C. Harrison3 & Tom A. Rapoport1 1Howard Hughes Medical Institute and Department of Cell Biology, Harvard Medical School, 240 Longwood Avenue, Boston, Massachusetts 02115, USA 2Max Planck Institute of Biophysics, Marie-Curie-Strasse 13-15, D-60439 Frankfurt am Main, Germany 3Howard Hughes Medical Institute, Children’s Hospital and Harvard Medical School, 320 Longwood Avenue, Boston, Massachusetts 02115, USA 4University Luebeck, Institute for Biology, Ratzeburger Allee 160, Luebeck, D-23538, Germany * These authors contributed equally to this work ........................................................................................................................................................................................................................... A conserved heterotrimeric membrane protein complex, the Sec61 or SecY complex, forms a protein-conducting channel, allowing polypeptides to be transferred across or integrated into membranes. We report the crystal structure of the complex from Methanococcus jannaschii at a resolution of 3.2 A˚ . The structure suggests that one copy of the heterotrimer serves as a functional translocation channel. The a-subunit has two linked halves, transmembrane segments 1–5 and 6–10, clamped together by the g-subunit. A cytoplasmic funnel leading into the channel is plugged by a short helix. Plug displacement can open the channel into an ‘hourglass’ with a ring of hydrophobic residues at its constriction. This ring may form a seal around the translocating polypeptide, hindering the permeation of other molecules. The structure also suggests mechanisms for signal-sequence recognition and for the lateral exit of transmembrane segments of nascent membrane proteins into lipid, and indicates binding sites for partners that provide the driving force for translocation. -
Human Prostate Cancer Cell Apoptosis
HUMAN PROSTATE CANCER CELL APOPTOSIS INDUCED BY INTERFERON-γ AND DOUBLE-STRANDED RNA AND STUDIES ON THE BIOLOGICAL ROLES OF TRANSMEMBRANE AND COILED-COIL DOMAINS 1 HAIYAN TAN Bachelor of Science in Medicine Norman Bethune University of Medical Sciences, China July, 1995 Submitted in partial fulfillment of the requirements for the degree DOCTOR OF PHILOSOPHY IN CLINICAL AND BIOANALYTICAL CHEMISTRY at the CLEVEALND STATE UNIVERSTIY August, 2010 This dissertation has been approved for the Department of Chemistry and the College of Graduate Studies by Dissertation Committee Chairperson, Dr. Aimin Zhou Department & Date Dr. David Anderson Department & Date Dr. Xue-long Sun Department & Date Dr. Crystal M Weyman Department & Date Dr. Sihe Wang Department & Date ACKNOWLEDGEMENTS First and foremost, I want to heartily thank my advisor, Dr. Aimin Zhou, for his exceptional mentorship and constant support throughout my Ph.D. work. He was always available to listen to and discuss my ideas and questions, and showed me different ways to research problems. Most importantly, he taught me the need to be persistent to accomplish any goal, and his optimistic attitude toward his career and life has deeply affected me. I would like to express my special appreciation to my advisory committee, Dr. David Anderson, Dr. Crystal M Weyman, Dr. Sihe Wang, and Dr. Xue-long Sun, for their advice, encouragement, and support. Dr. Anderson provided me with a lot of encouragement and support. His instruction for my first job interview in the United States really touched me. Dr. Weyman is a model of a successful woman scientist and her instruction is always helpful. -
Structure of the Human Signal Peptidase Complex Reveals the Determinants for Signal Peptide Cleavage
bioRxiv preprint doi: https://doi.org/10.1101/2020.11.11.378711; this version posted November 11, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license. Structure of the Human Signal Peptidase Complex Reveals the Determinants for Signal Peptide Cleavage A. Manuel Liaci1, Barbara Steigenberger2,3, Sem Tamara2,3, Paulo Cesar Telles de Souza4, Mariska Gröllers-Mulderij1, Patrick Ogrissek1,5, Siewert J. Marrink4, Richard A. Scheltema2,3, Friedrich Förster1* Abstract The signal peptidase complex (SPC) is an essential membrane complex in the endoplasmic reticulum (ER), where it removes signal peptides (SPs) from a large variety of secretory pre-proteins with exquisite specificity. Although the determinants of this process have been established empirically, the molecular details of SP recognition and removal remain elusive. Here, we show that the human SPC exists in two functional paralogs with distinct proteolytic subunits. We determined the atomic structures of both paralogs using electron cryo- microscopy and structural proteomics. The active site is formed by a catalytic triad and abuts the ER membrane, where a transmembrane window collectively formed by all subunits locally thins the bilayer. This unique architecture generates specificity for thousands of SPs based on the length of their hydrophobic segments. Keywords Signal Peptidase Complex, Signal Peptide, Protein Maturation, Membrane Thinning, cryo-EM, Crosslinking Mass Spectrometry, Molecular Dynamics Simulations, Protein Secretion, ER Translocon 1Cryo-Electron Microscopy, Bijvoet Centre for Biomolecular Research, Utrecht University, Padualaan 8, 3584 CH Utrecht, The Netherlands. -
Homozygous Frameshift Mutation in TMCO1 Causes a Syndrome with Craniofacial Dysmorphism, Skeletal Anomalies, and Mental Retardation
Homozygous frameshift mutation in TMCO1 causes a syndrome with craniofacial dysmorphism, skeletal anomalies, and mental retardation Baozhong Xina, Erik G. Puffenbergerb,c, Susan Turbena, Haiyan Tand, Aimin Zhoud, and Heng Wanga,e,f,1 aDDC Clinic for Special Needs Children, Middlefield, OH 44062; bThe Clinic for Special Children, Strasburg, PA 17579; cDepartment of Biology, Franklin and Marshall College, Lancaster, PA 17603; dDepartment of Chemistry, Cleveland State University, Cleveland, OH 44115; eDepartment of Pediatrics, Rainbow Babies and Children’s Hospital, Cleveland, OH 44106; and fDepartment of Molecular Cardiology, Cleveland Clinic, Cleveland, OH 44195 Edited by Albert de la Chapelle, Ohio State University Comprehensive Cancer Center, Columbus, OH, and approved November 18, 2009 (received for review July 27, 2009) We identified an autosomal recessive condition in 11 individuals Results in the Old Order Amish of northeastern Ohio. The syndrome was Clinical Phenotype. TMCO1 defect syndrome was diagnosed in 11 characterized by distinctive craniofacial dysmorphism, skeletal individuals (6 males, 5 females) ranging in age from 3 to 39 years. anomalies, and mental retardation. The typical craniofacial dys- All 11 patients demonstrated Old Order Amish ancestry, and morphism included brachycephaly, highly arched bushy eye- genealogical analyses revealed multiple lines of common descent brows, synophrys, long eyelashes, low-set ears, microdontism of between all parents of affected children (Fig. 1). The phenotype primary teeth, and generalized gingival hyperplasia, whereas was not observed in the parents or 23 unaffected siblings. Sprengel deformity of scapula, fusion of spine, rib abnormities, A history of first trimester spontaneous abortions was reported pectus excavatum, and pes planus represented skeletal anomalies. -
Identification of Differentially Expressed Genes in Human Bladder Cancer Through Genome-Wide Gene Expression Profiling
521-531 24/7/06 18:28 Page 521 ONCOLOGY REPORTS 16: 521-531, 2006 521 Identification of differentially expressed genes in human bladder cancer through genome-wide gene expression profiling KAZUMORI KAWAKAMI1,3, HIDEKI ENOKIDA1, TOKUSHI TACHIWADA1, TAKENARI GOTANDA1, KENGO TSUNEYOSHI1, HIROYUKI KUBO1, KENRYU NISHIYAMA1, MASAKI TAKIGUCHI2, MASAYUKI NAKAGAWA1 and NAOHIKO SEKI3 1Department of Urology, Graduate School of Medical and Dental Sciences, Kagoshima University, 8-35-1 Sakuragaoka, Kagoshima 890-8520; Departments of 2Biochemistry and Genetics, and 3Functional Genomics, Graduate School of Medicine, Chiba University, 1-8-1 Inohana, Chuo-ku, Chiba 260-8670, Japan Received February 15, 2006; Accepted April 27, 2006 Abstract. Large-scale gene expression profiling is an effective CKS2 gene not only as a potential biomarker for diagnosing, strategy for understanding the progression of bladder cancer but also for staging human BC. This is the first report (BC). The aim of this study was to identify genes that are demonstrating that CKS2 expression is strongly correlated expressed differently in the course of BC progression and to with the progression of human BC. establish new biomarkers for BC. Specimens from 21 patients with pathologically confirmed superficial (n=10) or Introduction invasive (n=11) BC and 4 normal bladder samples were studied; samples from 14 of the 21 BC samples were subjected Bladder cancer (BC) is among the 5 most common to microarray analysis. The validity of the microarray results malignancies worldwide, and the 2nd most common tumor of was verified by real-time RT-PCR. Of the 136 up-regulated the genitourinary tract and the 2nd most common cause of genes we detected, 21 were present in all 14 BCs examined death in patients with cancer of the urinary tract (1-7).